Dimensional Fund Advisors LP Catalyst Biosciences, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.36 - $1.78 $27,765 - $137,286	-77,127 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.51 - $1.0 $211,942 - $415,574	-415,574 Reduced 84.35%	77,127 $51,000
Q4 2021 Feb 09, 2022	SELL	$0.91 - $4.16 $280,952 - $1.28 Million	-308,739 Reduced 38.52%	492,701 $450,000
Q3 2021 Nov 12, 2021	SELL	$3.78 - $5.18 $469,725 - $643,697	-124,266 Reduced 13.42%	801,440 $3.29 Million
Q2 2021 Aug 12, 2021	BUY	$4.1 - $5.33 $74,251 - $96,526	18,110 Added 2.0%	925,706 $4.01 Million
Q1 2021 May 14, 2021	BUY	$4.93 - $7.15 $578,915 - $839,603	117,427 Added 14.86%	907,596 $4.57 Million
Q4 2020 Feb 25, 2021	BUY	$4.55 - $7.29 $3.6 Million - $5.76 Million	790,169 New	790,169 $4.99 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.